Results 31 to 40 of about 768,287 (304)

Thrombin-Receptor Activation and Thrombin-Induced Brain Tolerance [PDF]

open access: yesJournal of Cerebral Blood Flow & Metabolism, 2002
The authors previously found that pretreatment with a low dose of thrombin attenuates the brain edema induced by a large dose of thrombin or an intracerebral hemorrhage, and reduces infarct volume after focal cerebral ischemia (i.e., thrombin preconditioning).
Yajun, Jiang   +6 more
openaire   +2 more sources

Effects of thrombin, PAR-1 activating peptide and a PAR-1 antagonist on umbilical artery resistance in vitro

open access: yesReproductive Biology and Endocrinology, 2005
Background The non-thrombotic effects of thrombin in cardiovascular tissues, as mediated via the protease activated receptors (PARs), and particularly PAR-1, have been the focus of much recent research. The aims of this study were to evaluate the effects
Elliott John T   +5 more
doaj   +1 more source

C1-inhibitor influence on platelet activation by thrombin receptors agonists

open access: yesClinical and Applied Thrombosis/Hemostasis, 2022
Introduction Protease activated receptors 1 (PAR1) and 4 (PAR4) agonists are used to study platelet activation. Data on platelet activation are extrapolated across experimental settings.
Ivan D. Tarandovskiy PhD   +2 more
doaj   +1 more source

Protease activated receptors 1 and 4 sensitize TRPV1 in nociceptive neurones

open access: yesMolecular Pain, 2010
Protease-activated receptors (PAR1-4) are activated by proteases released by cell damage or blood clotting, and are known to be involved in promoting pain and hyperalgesia.
Magherini Pier C   +7 more
doaj   +1 more source

Mechanisms of thrombin-Induced myometrial contractions: Potential targets of progesterone.

open access: yesPLoS ONE, 2020
Intrauterine bleeding during pregnancy is a major risk factor for preterm birth. Thrombin, the most abundant coagulation factor in blood, is associated with uterine myometrial contraction.
Fumitomo Nishimura   +5 more
doaj   +1 more source

Regulation of Acetylcholine Quantal Release by Coupled Thrombin/BDNF Signaling in Mouse Motor Synapses

open access: yesCells, 2019
The aim of this study was to compare the acute effects of thrombin and brain-derived neurotrophic factor (BDNF) on spontaneous miniature endplate potentials (MEPPs) and multiquantal evoked endplate potentials (EPPs) in mouse neuromuscular junctions (NMJs)
Alexander Gaydukov   +6 more
doaj   +1 more source

Induction of Tumor Necrosis Factor (TNF) Release from Subtypes of T Cells by Agonists of Proteinase Activated Receptors

open access: yesMediators of Inflammation, 2013
Serine proteinases have been recognized as playing an important role in inflammation via proteinase activated receptors (PARs). However, little is known about the influence of serine proteinases and PARs on TNF secretion from highly purified T cells.
Haiwei Yang   +4 more
doaj   +1 more source

Calcium mobilization and protein kinase C activation downstream of protease activated receptor 4 (PAR4) is negatively regulated by PAR3 in mouse platelets. [PDF]

open access: yesPLoS ONE, 2013
Thrombin activates platelets through protease activated receptors (PARs). Mouse platelets express PAR3 and PAR4. PAR3 does not signal in platelets. However, PAR4 is a relatively poor thrombin substrate and requires PAR3 as a cofactor at low thrombin ...
Amal Arachiche   +2 more
doaj   +1 more source

Thrombin Receptor Structure and Function

open access: yesCold Spring Harbor Symposia on Quantitative Biology, 1992
Thrombin is a multifunctional serine protease generated at sites of vascular injury. While it is best known for its ability to cleave fibrinogen and trigger fibrin formation, thrombin is also a powerful agonist for a variety of cellular responses. First and foremost, thrombin is the most potent activator of platelets in vitro.
S R, Coughlin   +3 more
openaire   +2 more sources

Platelet thrombin receptor antagonism and atherothrombosis [PDF]

open access: yesEuropean Heart Journal, 2009
Clinical manifestations of atherothrombotic disease, such as acute coronary syndromes, cerebrovascular events, and peripheral arterial disease, are major causes of mortality and morbidity worldwide. Platelet activation and aggregation are ultimately responsible for the progression and clinical presentations of atherothrombotic disease.
ANGIOLILLO DJ   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy